Tungsten
RTECS #
YO7175000
CAS #
Updated
September 2018
Molecular Weight
183.85
Molecular Formula
W
Synonyms
Wolfram
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 500 mg/24H | mild | 28ZPAK -,19,1972 |
skin /rabbit | 500 mg/24H | mild | 28ZPAK -,19,1972 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | 1210 µg/kg (35W prior to copulation) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Specific developmental abnormalities: Musculoskeletal system | GISAAA 42(8),30,1977 |
oral/rat | 1160 µg/kg (30W prior to copulation/1-20D pregnant) | Reproductive: Specific developmental abnormalities: Musculoskeletal system | FATOAO 41,620,1978 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
In Vitro/Human, kidney | Inhibitor Concentration Low: 200 mg/L/24H | In Vitro Toxicity Studies: Cell viability (lysosomal damage): neutral red assay etc. In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TXAPA9 253,178,2011 |
In Vitro/Human, kidney | Inhibitor Concentration Low: 1000 µmol/L/24H | In Vitro Toxicity Studies: Other assays | TXAPA9 253,178,2011 |
In Vitro/jah | Inhibitor Concentration Low: 100 mg/L/24H | In Vitro Toxicity Studies: Cell viability (lysosomal damage): neutral red assay etc. | TXAPA9 253,178,2011 |
In Vitro/max | Inhibitor Concentration Low: 100 mg/L/1W | In Vitro Toxicity Studies: Cell viability (lysosomal damage): neutral red assay etc. In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TXAPA9 253,178,2011 |
In Vitro/Mouse, leukemia cells | Inhibitor Concentration Low: 100 mg/L/4H | In Vitro Toxicity Studies: Cell metabolic activity: Alamar Blue assay etc. | TXAPA9 259,74,2012 |
intraperitoneal/rat | lethal dose (50 percent kill): 5 gm/kg | Vascular: Regional or general arteriolar or venous dilation Liver: Other changes Blood: Other changes | INMEAF 15,482,1946 |
intratracheal/rat | lowest published toxic dose: 200 mg/kg | Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | HBTME* -,871,2007 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 5 mg(week)/m3;short term exposure limit 10 mg(week)/m3 | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 5 mg/m3;short term exposure limit 10 mg/m3 | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | ENTOX* -,392,2005 | |
TOXICOLOGY REVIEW | HBTME* ,871,2007 | |
TOXICOLOGY REVIEW | NTAPM* -,629,1995 | |
TOXICOLOGY REVIEW | TOLED5 265,106,2017 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD | air-time-weighted average 5 mg/m3 (insoluble) | DTLVS* 3,272,1971 |
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 1 mg/m3 (soluble) | DTLVS* 3,272,1971 |
Occupational Exposure Limit-AUSTRIA | MAK-TMW 5 mg/m3;KZW 10 mg/m3, inhal, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 5 mg/m3, short term exposure limit 10 mg/m3, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 5 mg(W)/m3 (dust), MAY2011 | |
Occupational Exposure Limit-ICELAND | time-weighted average 5 mg/m3, dust, NOV2011 | |
Occupational Exposure Limit-MEXICO | time-weighted average 5 mg(W)/m3;short term exposure limit 10 mg(W)/m3, 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 1 mg(W)/m3, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 5 mg/m3, JAN1999 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) fume and dust 5 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | time-weighted average 6 mg/m3, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 5 mg/m3, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 5 mg/m3, inhal, JAN2011 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 5 mg/m3;short term exposure limit 10 mg/m3, OCT2007 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO TUNGSTEN, insoluble-air | time-weighted average 5 mg(W)/m3;short term exposure limit 10 mg/m3 | NIOSH* DHHS #92-100,1992 |
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO TUNGSTEN, soluble-air | 10H time-weighted average 1 mg(W)/m3;short term exposure limit 3 mg/m3 | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code X5928; Number of Industries 4; Total Number of Facilities 53; Number of Occupations 11; Total Number of Employees Exposed 3907; Total Number of Female Employees Exposed 1258 | |
National Occupational Exposure Survey 1983 | Hazard Code X7685; Number of Industries 5; Total Number of Facilities 174; Number of Occupations 15; Total Number of Employees Exposed 4822; Total Number of Female Employees Exposed 3021 | |
National Occupational Exposure Survey 1983 | Hazard Code 74980; Number of Industries 52; Total Number of Facilities 1623; Number of Occupations 43; Total Number of Employees Exposed 38323; Total Number of Female Employees Exposed 3591 | |
National Occupational Hazard Survey 1974 | Hazard Code 74980; Number of Industries 20; Total Number of Facilities 530; Number of Occupations 24; Total Number of Employees Exposed 4735 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health